Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply.

Saved in:
Bibliographic Details
Title: Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply.
Authors: Subbiah, Vivek1 (AUTHOR), Lassen, Ulrik2 (AUTHOR), Gasal, Eduard3 (AUTHOR), Burgess, Paul4 (AUTHOR), Wainberg, Zev A5 (AUTHOR)
Source: Lancet Oncology. Nov2020, Vol. 21 Issue 11, pe516-e516. 1p.
Database: Academic Search Ultimate
Description
ISSN:14702045
DOI:10.1016/S1470-2045(20)30625-2